Patients
Sex (% male)
Median age at the first observation (IQR
a
)
Median Nadir %CD4+ (IQR
a
)
HIV viral load Median (range)
% ARV
b
Long Term Non-Progressor
26 (22.8%)
23.1%
5.42 (1.50-10.29)
28.5% (25.0-32.0)
400 (50-2500)
0.0
Slow Progressor
9 (7.9%)
88.9%
5.51 (4.51-7.20)
23.0% (19-25)
2300 (50-30000)
0.0
Fast Progressor
23 (20.2%)
60.9%
3.97 (2.10-6.68)
13% (9-17)
73000 (5280-500000)
68.2
Uncertain
56 (49.1%)
57.1%
1.79 (1.32-28.88)
21.5% (17-34)
14500 (400-270000)
100.0
a
IQR Inter-quartile range.
b
% of patients which started antiretroviral therapy.
Table 1:
Demographic, immunological and therapeutic characteristics of the study groups classified according clinical progression.
Goto home»
